Home Cart 0 Sign in  
X

[ CAS No. 256936-02-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 256936-02-4
Chemical Structure| 256936-02-4
Chemical Structure| 256936-02-4
Structure of 256936-02-4 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 256936-02-4 ]

Related Doc. of [ 256936-02-4 ]

Alternatived Products of [ 256936-02-4 ]

Product Details of [ 256936-02-4 ]

CAS No. :256936-02-4 MDL No. :MFCD23706340
Formula : C10H8ClNO2 Boiling Point : -
Linear Structure Formula :- InChI Key :GXXVVVAPNVMAGE-UHFFFAOYSA-N
M.W : 209.63 Pubchem ID :53863223
Synonyms :

Calculated chemistry of [ 256936-02-4 ]

Physicochemical Properties

Num. heavy atoms : 14
Num. arom. heavy atoms : 9
Fraction Csp3 : 0.1
Num. rotatable bonds : 2
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 54.59
TPSA : 42.09 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.78 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.18
Log Po/w (XLOGP3) : 2.53
Log Po/w (WLOGP) : 2.61
Log Po/w (MLOGP) : 1.94
Log Po/w (SILICOS-IT) : 2.99
Consensus Log Po/w : 2.45

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.08
Solubility : 0.175 mg/ml ; 0.000837 mol/l
Class : Soluble
Log S (Ali) : -3.06
Solubility : 0.182 mg/ml ; 0.00087 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.98
Solubility : 0.0218 mg/ml ; 0.000104 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.62

Safety of [ 256936-02-4 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 256936-02-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 256936-02-4 ]

[ 256936-02-4 ] Synthesis Path-Downstream   1~1

YieldReaction ConditionsOperation in experiment
83% With potassium <i>tert</i>-butylate In 1-methyl-pyrrolidin-2-one at 20℃; for 18h; 79-2 Preparation Example 64-3: synthesis of 7-chloro-2-methyl-1H-indole-5-carboxylic acid methyl ester General procedure: 4-Amino-3-chloro-5-prop-1-ynyl-benzoic acid methyl ester (1.7 g, 7.6 mmol) obtained from Preparation Example 64-2 was dissolved in N-methylpyrrolidone, and potassium t-butoxide (840 mg, 7.6 mmol) was slowly added dropwise thereto. The mixture was stirred for 18 hours at room temperature, added with 1N hydrochloric acid aqueous solution and extracted with ethyl acetate. The extract was washed with brine, dried with anhydrous magnesium sulfate and filtered. The filtrate was distilled under reduced pressure. The residue was separated by column chromatography to obtain the title compound (1.4 g, 82%). [990] NMR: 1H-NMR (400HMz, CDCl3); δ 8.30(s, 1H), 8.17(s, 1H), 7.83(s, 1H), 6.35(s, 1H), 3.92(s, 3H), 2.49(s, 3H)
65.D methyl-7-chloro-5-indole-carboxylate EXAMPLE 65D methyl-7-chloro-5-indole-carboxylate 5-Bromo-7-chloro-indole was processed as described in Example 63C to provide the desired product. MS (ESI(+)) m/z 210 (M+H)+and 227 (M+NH4)+; 1H NMR (CDCl3) δ 8.58 (s, 1H), 8.33 (s, 1H), 7.92 (d, J=l.1 Hz, 1H), 7.33 (m, 1H), 6.70 (dd, J=2.2, 2.9 Hz, 1H), 3.94(s, 3H).
Same Skeleton Products
Historical Records